Introduction {#sec1-1}
============

Beauty consciousness and the knowledge of application of herb, mineral, and animal products are as old phenomena as the human existence. *Ayurveda* determines beauty by *Prakriti* (body constitution), *Sara* (structural predominance), *Samhanana* (compactness of body), *Tvak* (skin), *Pramana* (measurement), and *Dirghayu Lakshana* (symptom of long life).\[[@ref1]\] Beauty is the desire of every individual to give pleasure to the sense. Melanin pigmentation is a group of disorders characterized by abnormal color of skin that results from increased or decreased melanin production from a normal number of melanocytes in the skin. It includes both hypermelanosis and hypomelanosis. In hypermelanosis, there is formation of flat, distinct, discolored area of skin \<1 cm widely known as macules and areas of discoloration that are larger than 1 cm which are referred to as patches particularly on face. Melanin pigmentation disorder can be correlated with *Tvakvaivarnya* in *Ayurveda*, but in this study, hypermelanosis has been considered as *Tvakvaivarnya*. According to commentators *Arunadatta* and *Hemadri*, the meaning of *Vaivarnya* is "diversity from normal color or complexion which is not like the normal color of *Tvacha* (skin).\[[@ref2][@ref3]\] Hence, the term *Tvakvaivarnya* means the abnormality in the color of *Tvacha*, i.e., the discoloration of skin. *Ayurveda* considers all skin disorders as a *Kushtha* and some conditions are mentioned under *Kshudra Roga*. In *Ashtanga Hridaya Nidana Sthana* chapter 14, it has been described that the conditions responsible for *Tvak*v*aivarnya* (hypermelanosis) are considered as a *Kushtha*.\[[@ref4]\] *Kushtha* runs as a chronic disease which is generally considered as difficult to cure and even if it is cured relapses are common. Though modern medical treatments are cheaper and easily available, they are not useful for complete cure of the disease, whereas surgical treatment requires costly instrument, as well as a high skill. This work was an effort to explore the Ayurvedic line of management of *Tvaka Vaivarnya*. Hence, in the present study, an attempt has been made to find out some potent and perfect remedy for *Tvakvaivarnya* (hypermelanosis), which is useful to regain the original beauty of face and to add an esthetic value to the personality. *Varnaprasadana*,\[[@ref5]\] which has been described as bringing out the clarity of *Varna*, is thus applicable in *Tvakvaivarnya* (hypermelanosis). The whole study was designed with the hypothesis of finding out the *Varnaprasadana* effect of *Mukhakantivardhaka Lepa* and *Patoladi Ghanavati* in the disease *Tvakvaivarnya* (hypermelanosis).

Materials and Methods {#sec1-2}
=====================

A total of 62 patients irrespective of sex, caste, religion, and socioeconomic status who were diagnosed to have *Tvakvaivarnya* (hypermelanosis) were selected from the outpatient department (OPD) of Basic Principle, IPGT & RA, Jamnagar, Gujarat, India. The study was approved by the IPGT & RA's Institutional Ethics Committee (No--PGT/7/-A/Ethics/2015-16/1470, Dt. 25/08/15). The study has been registered in Clinical Trial Registry, India (No. CTRI/2016/02/006690). An informed consent was obtained from each patient before starting the course of treatment. Fair and lovely color grading scales has been used to assess the color of *Vivarna Mandala* (Discolored patches).

The study was an open-labeled random clinical trial. Sampling technique was simple random sampling by lottery method.

Diagnostic criteria {#sec2-1}
-------------------

Patients were diagnosed and assessed thoroughly on the basis of *Ayurvedic* classical signs and symptoms of *Tvakvaivarnya* (hypermelanosis) and were examined on the basis of a specially prepared proforma along with a detailed history. All the patients were subjected to routine hematological examination (hemoglobin%, total white blood cell (WBC), differential leucocyte count (DLC), total red blood cell count (RBC) and blood group and biochemistry investigation \[Random Blood sugar (RBS), S.G.P.T., S.G.O.T, Serum bilirubin\] to assess the general condition before treatment.

Inclusion criteria {#sec2-2}
------------------

Patients having *Tvakvaivarnya* (hypermelanosis) on facePatients aged between 16 and 40 yearsPatients were selected without any bar of race, religion, sex etc.

Exclusion criteria {#sec2-3}
------------------

Patients having *Tvakvaivarnya* (hypermelanosis) as the symptom of major systemic disease or as a result of side effect of any drugsPatients having any allergic conditionPatients having *Tvakvaivarnya* (hypermelanosis) due to hormonal causesPatients having the chronicity of disease for more than 3 yearsPatients having *Tvakvaivarnya* (hypermelanosis) since birth such as nevus of OTA etc.Patients aged \<16 years and \>40 years were excluded from the study.

Drug {#sec2-4}
----

Both *Mukhakantivardhaka Lepa* and *Patoladi Ghanavati* were prepared in the Pharmacy of Gujarat Ayurved University, Jamnagar. *Mukhakantivardhaka Lepa* is the formulation mentioned in *Sharangadhara Samhita* of *Sharangadhara*, *Uttara Khanda*, chapter 11, which acts as *Vyangaghna* and *Mukhakantida*.\[[@ref6]\] *Patoladi Ghanavati* is a formulation mentioned in *Chakradatta*, *Visarpa-Visphota Chikitsa*. It acts as *Pitta-Shleshmahara*, *Kandunashaka* and *Tvakdosha Nashaka*\[[@ref7]\] \[Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}\].

###### 

Ingredients of *Mukhakantivardhaka Lepa*

![](AYU-38-39-g001)

###### 

Contents of *Patoladi Ghanavati*
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Grouping: All the patients were divided into two groups as follows: \[[Table 3](#T3){ref-type="table"}\]

###### 

Drug selection and posology

![](AYU-38-39-g003)

Group A: In this group, 31 patients were treated with *Mukhakantivardhaka Lepa*Group B: In this group, 31 patients were treated with *Patoladi Ghanavati*.

General observation {#sec2-5}
-------------------

A total of 62 patients were registered in the present study who were divided into two groups, of which 60 patients completed the treatment and 2 patients had withdrawn the treatment against medical advice. A majority of the patients, i.e., 51.31% belonged between 25 and 32 years of age group, 95.1% patients were Hindu, 79.03% patients were female and 41.9% were belonging to upper middle class. Majority of the patients, i.e., 51.6% had completed postgraduation, 78.33% were addicted to tea and 100% were from the *Sadharana Desha*. A majority, i.e., 80.6% of the patients reported consuming *Katu* (91.9%) *Amla* and *Lavana* (59.6%), *Rasa* and *Ushna (*62.9%) and *Ruksha Guna*-dominant diet (64.5%). Nearly 72.5% of patients had *Madhyama Abhyavaharana Shakti* (eating capacity), 69.3% had *Madhyama Jarana Shakti* (digestive capacity), 77.4% had *Madhyama Satva*, 46.7% of patients had *Vishamagni*, 29% of patients had *Mandagni*, 61.29% of patients had chronicity of 1--3 years, 70.9% had progressive disease and 45.1% of patients had exposure to sun rays as an aggravating factor. Tension as an aggravating factor was observed in approximately 54.8% of the patients, 58% of the patients had irregular bowel habits, and 51.61% of the patients had *Krura Koshtha*. Majority of patients (59.67%) had *Vata-Pittaja Prakriti*, 100% of patients had both *Rasa* and *Rakta Dhatu* vitiation, 29.03% had a positive family history and 64.5% had a positive past history of this disease. Among them, 77.4% of the patients had macule and 25.8% had patch.

The chief complaint of *Vivarnamandala* was seen in all the patients in the present study. As associated symptoms, a majority, i.e., 53.22% of patients had *Daha* (burning sensation), 83.8% had *Rukshata* (dryness), 16.12% had *Snigdhata* and 93.5% had *Kandu* (itching).

Total Effect of therapy: {#sec2-6}
------------------------

Steps for calculating overall percentage of improvement of individual patient:

All the BT score before treatment of every symptom of a patient is added.

All the AT scores after treatment of every symptom of that patient is added.

Overall percentage of improvement of each patient was calculated by the formula:

![](AYU-38-39-g004.jpg)

STATISTICAL ANALYSIS: {#sec2-7}
---------------------

The obtained data was analyzed statistically and presented as mean ± SEM (Standard Error of Mean). The change in sign and symptom scores was analyzed by 'Wilcoxon Signed rank test'. The values were considered significant at the levels of *p* \<0.05, *p* \<0.01 and *p* \<0.001.

Results {#sec1-3}
=======

The score for color of patches was reduced by 61% in Group A, which was statistically highly significant (*P* \< 0.001), while it was reduced by 59.75% in Group B, which was also statistically highly significant (*P* \< 0.001). The score of numbers of the patches was reduced by 58.4% in Group A, which was statistically highly significant (*P* \< 0.001), while in Group B, it was reduced by 58.6%, which was also statistically highly significant (*P* \< 0.001). The affected area was reduced by 55.6% in Group A, which was statistically highly significant (*P* \< 0.001), while in Group B, it was reduced by 57.8%, which was also statistically highly significant (*P* \< 0.001) \[Figures [1](#F1){ref-type="fig"}--[8](#F8){ref-type="fig"}\].

![Patient 1 -- (a) Before treatment (Macule)\[Group -A\]](AYU-38-39-g005){#F1}
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![Patient 2 -- (b) After treatment (Patch ) \[Group -A\]](AYU-38-39-g008){#F4}
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![Patient 1 -- (b) After treatment (Macule)\[Group -B\]](AYU-38-39-g010){#F6}
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![Patient 2 -- (b) After treatment (Patch)\[Group -B\]](AYU-38-39-g012){#F8}

Chief complaints {#sec2-8}
----------------

Percentage wise, both the groups showed equal results. Highly significant results were found in both the groups \[[Table 4](#T4){ref-type="table"}\].

###### 

Total effect of therapy on chief complaints of sixty patients
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Associated complaints {#sec2-9}
---------------------

Percentage wise, both the groups shows equal results. Highly significant results were found in both the groups \[Tables [5](#T5){ref-type="table"}--[7](#T7){ref-type="table"}\].

###### 

Total effect of therapy on associated complaints of sixty patients
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###### 

Overall effect on chief & associated complaints of sixty patients
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###### 

Overall effect of therapy in both groups
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Discussion {#sec1-4}
==========

A majority of patients (79.03%) were females, as females have more changes in their hormonal level of concentrations due to monthly cycles and as a result they are more prone to have *Tvakvaivarnya* (hypermelanosis) in certain age groups and at certain times than males. A majority of patients (53.2%) were belonging to upper middle class. The awareness of esthetic problem initiates them to visit the hospital for consultation. A majority, i.e., 51.6% of the patients had completed their postgraduation. Among all the patients, 78.33% of patients were addicted to tea. By its virtue, causing *Vidaha* of *Rakta*, it increases the *Ushna-Tikshna Guna* of *Agni*. Further it cause *Dhatvagni Dushti* which mainly leas to formation of *Dushti Rasa* and *Rakta Dahtu*. Leading to *Tvaka Vaivarnya*. Here in this study maximum number of patients were student (70.9%) working man & women (12.8%). so they all head to stay outside their house for 8-9 hour per day. due to this face was directly exposed to the external environment and got easily affected by the environmental changes. *Lepa* should not apply at night according to our classics, that's why evening time was choosen for the time of drug application. As *Yakrita* and *Pliha* are the root organs of *Raktavaha Srotasa*, they also have a definite role in vitiation of *Rakta Dhatu*, which is the prime cause of *Tvakvaivarnya* (hypermelanosis). Moreover, the main sites of patches were cheeks, forehead, perioral area, chin and nose in most of the patients, as they are exposed to sun light directly. A majority of patients reported consuming *Katu* (Hot)*, Amla* (Sour)*, Lavana* (Salty) *Rasa and Ushna* (Hot) *Guna* (Property)*-*dominant diet. This type of diet aggravates the *Pitta Dosha* in the body which first vitiates the *Rakta Dhatu* and may result in *Varna Vikriti* (Discoloration). A majority of the patients had the habit of *Viruddhashana* (87%) and *Adhyashana* (59.6%). It hampers the state of *Agni* which leads to *Dosha Prakopa* (vitiation) giving rise to many diseases. In the present study, a majority of the patients (72.5%) reported with *Madhyama Abhyavaharana Shakti* (eating capacity), but a maximum number of patients (69.3%) were having *Madhyama Jarana Shakti* (digestive capacity). As a result, *Mandagni* (loss of appetite) was found in 29% of the patients whereas 46.7% of patients were having *Vishamagni* (irregular appetite). *Acharya Charaka* has stated that the wholesome food consumed in appropriate quantity by the respective *Agni* (digestive enzymes) according to the prescribed method certainly helps the individual in bringing out complexion without disturbing any elements.\[[@ref8][@ref9][@ref10]\] Hence, excess intake by impairing the status of *Agni* (digestive enzymes) can be considered as a cause of *Tvakvaivarnya* (hypermelanosis) due to *Rasa* and *Rakta Dushti*.\[[@ref11]\] About 54.8% of patients had a distressed status of mind. Distressed, as an aggravating factor, was observed in approximately 66.1% of the patients. Moreover, a maximum number of the patients (77.4%) were of *Madhyama Sattva*. All these highlight the role of mental factor in causing the disease, and hence psychological factor is assigned as a cause of *Vaivarnya*. Out of 19 married patients, most of the patients had abnormal obstetric history, i.e., either abortion/miscarriage or cesarean. This can induce increased blood level of melanocytes stimulating hormone and stimulation of melanocyte activity. The increase in estrogen and progesterone may also play a role. Among the patients, associated symptoms were present in most of the patients, *Daha (*53.22%) and *Rukshata* (83.8%) were observed in majority of the patients, which is probably due to the involvement of *Pitta* and *Vata Dosha* in the disease.

Here, *Kandu* was observed in 93.5% of patients. Though *Kandu* mainly occurs due to the involvement of *Kapha Dosha*, vitiation or aggravation of *Vata Dosha* also leads to extreme dryness in the body and also in the nerves. The irritability in skin and nerves leads to *Kandu* (itching). This is the reason why a maximum number of patients were complaining of *Kandu*. In this study, a majority of the patients were using cosmetics such as bleaching cream, foundation cream and compact powder. All these are *Tikshna* and *Ruksha* and hence directly cause the *Dushti* of *Bhrajaka Pitta* and cause the disease. And also, they aggravate the disease, which was observed in most of the patients (50%). Family history was positive in the majority of patients (29%). Among these patients, family history was observed positive in most of the patients from maternal side. *Tvak* is mentioned as *Matrija Avayava*. Moreover, *Varna* is the entity which comes from the *Satmya* of mother. It suggests the role of genetic factor and modern science also considers the same thing. Past history was also present in some patients (64.51%). *Krura Koshtha* was observed in 51.61% of patients, and again a maximum number of patients (56.4%) reported with irregular bowel habits, i.e., either constipated or with efforts. This may be due to the *Vata Dosha*, which further leads to the disturbance in *Agni* and hence, it actively participates in causing the disease. Regarding color of the patches, Group A showed better result than Group B. In reducing the affected area of the patches, Group B showed better result than Group A. Both groups showed approximately equal result in reducing the number of patches.

Probable mode of action of *Mukhakantivardhaka lepa* {#sec2-10}
----------------------------------------------------

When *Dravya*, that is, *Mukhakantivardhak Lepa* having *Madhura* (Sweet)*, Kashaya* (Astringent) *and Tikta* (Bitter) is applied on *Tvaka* (Skin), by the process of *Nipata*, these *Rasas* act on *Bhrajaka Pitta*. The *Rasas* (taste) are said to possess two important *Karmas* that is *Chhedana* (Piercing) and *Upashamana* (alleviation).\[[@ref12]\] These *Rasas* do the *Chhedana* of *Prakupita* (vitiated), *Vata* and *Pitta* and *Upashamana*, which means that they do not allow the *Utklesha* of *Doshas* and maintain the equilibrium and thus pacify *Pitta* which is the main culprit in the causation of *Tvakvaivarnya*. Out of these seven drugs of *Lepa*, some of the drugs possess *Snigdha* (unctuous) *Guna* (property) and others possess *Laghu* (light) and *Ruksha* (dry) *Gunas*. *Snigdha Guna* is responsible for *Mardava* and *Varnaprasadana*, whereas *Laghu* and *Ruksha* are the properties of *Agneya Dravya*, which in turn are responsible for *Prabha*, *Prakasa* and *Varna*.\[[@ref13]\] Almost all the drugs selected are of *Shita Virya* and *Shita Virya Dravyas* which are endowed with *Rakta Prasadana Karma*. While explaining the direction for application of *Lepa*, it is said that the active principles of the drug enter through the *Sira Mukha*,\[[@ref14]\] hence after the entry of the drug by virtue of *Virya*, it enters the circulation. The selected drugs mainly are of *Katu Vipaka*. *Vipaka* is basically defined as *Karma Nishthaya*, here the term *Nishtha* incorporates *Jatharagni Dhatvagni* and *Bhutagni* irrespective of their order. By virtue of *Katu Vipak*, *Lepa* clears the unwanted metabolites *(Kledahara)* and *Meda lekhan*\[[@ref15]\] and causes *Prakrit Agni Karma*. Then, continuous application of *Lepa Dravya* causes normalization of *Bhrajakagni* that results in *Samyaka Paka* of *Lepa Dravya*. On the other hand, *Katu Vipaka* leads to *Srotoshuddhi* and *Samyaka Rasa vahana*, and ultimately gives *Varnaprasadana Karma*.

Probable mode of action of *Patoladi Ghanavati* {#sec2-11}
-----------------------------------------------

*Patoladi Ghanavati* possesses *Madhur*, *Tikta* and *Kashaya Rasas* with dominancy of *Guru*, *Snigdha Guna* and a combination of *Ushna* and *Shita Virya* drugs exhibiting *Tridoshshamaka* property, thereby exerting curative action on *Daha*, *Vrana* and acts as *Kushthaghna*. *Madhura Rasa* has properties of *Prasadan* and *Balavarnakara*. Hence, it improves fairness of the skin and bestows ideal skin texture. Due to *Prinana* property, possibly scar or *Vranavastu* gets healed which could be understood as providing nutrition to epidermal layer, maintaining its health. *Kashaya Rasa* brings about *Rukshata* and *Laghuta*, and reduces *Sharira Kleda*, which is primarily essential to achieve cure of the disease. *Tikta* and *Katu Rasas* have the properties of *Dipan* and *Pachan*, so they potentiate *Jathragni* and *Dhatvagni*. Further, they reduce the formation of *Ama*. With these properties, the drug causes *Pitta Shamana* and *Kapha Chhedana*, which leads to *Prakrit Agni Karma* and further causes *Samyak Ahara Rasa Nirmana*. Due to the predominance of *Ushna Virya* in the composition of *Patoladi Ghanavati*, it brings about pacification of *Vata Dosha* and also improves *Dhatvagni*. Due to *Katu Vipaka*, it causes *Srotoshuddhi* and *Uttarottar Dhatu Nirmana* which leads to the formation of normal *Rasa*, *Rakta Dhatu* and further leads to *Varnaprasadana*. And on the other hand, normal *Mamsa Dhatu* leads to the formation of normal *Upadhatu*, i.e., *Tvacha*.

Conclusion {#sec1-5}
==========

From this study, it can be concluded that *Mukhakantivardhaka Lepa* and *Patoladi Ghanavati* provide highly significant results in improving the color of patches and diminishing the intensity of the darkness and number of the patches. By the virtue of the *Varnaprasadana* drug, function of *Bhrajaka Pitta* is improved, disease can be controlled and the normal color of the skin can be regained. During the therapy, no untoward side effect was reported by any patient. Hence, *Mukhakantivardhaka Lepa* and *Patoladi Ghanavati* are safe and effective formulations which can be prescribed in *Tvakvaivarnya*.
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